Recce Pharmaceuticals (ASX:RCE) eyes US Defence grants with early data for R327 on burn wounds
ResMed (ASX:RMD) is still batting eyelashes at brokers, with Ord Minnett reaffirming its @Buy” rating following what it called a @solid” quarterly performance.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headl...
20 Aug 2025 13:41 (AEST)
Resmed has reported it received an exemption from the current US Administration, meaning it can keep sending its products from Australia.
24 Apr 2025 12:48 (AEST)
ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.
26 Apr 2024 13:45 (AEST)
Cloud-connected medical devices creator ResMed (ASX:RMD) has published its results for the first quarter of the 2024 fiscal year.
27 Oct 2023 12:02 (AEDT)
ResMed (ASX:RMD) has announced its financial results for Q4 FY23, highlighting RMD revenue increased by 23 per cent to $1.1 billion.
04 Aug 2023 11:26 (AEST)
ResMed (ASX:RMD) CEO Michael Farrell takes over the role of Chairman from his father, Peter Farrell, as company profit soars.
27 Jan 2023 13:48 (AEDT)
Nanocap Marquee Resources (ASX:MQR) has jumped nearly +20% in intraday trades heading into Friday afternoon after being the latest stock to declare a high-grade antimony intercept on-site its Mt Clement Project in WA. Headline results included an 8m intercept at 1.05% antimony from 137m depth and...